SARS-CoV-2-related Multisystem Inflammatory Syndrome in Adults
- PMID: 34912751
- PMCID: PMC8668002
- DOI: 10.12890/2021_003025
SARS-CoV-2-related Multisystem Inflammatory Syndrome in Adults
Abstract
Adults infected with SARS-CoV-2 may develop a multisystem inflammatory syndrome (MIS-A) characterized by elevated inflammatory markers and multisystem organ involvement. We report the case of a patient who presented with fever and vomiting at hospital admission. He tested positive for SARS-CoV-2 infection and blood tests showed elevated inflammatory markers. The patient developed acute cardiac dysfunction and shock in less than 24 hours and the echocardiogram revealed an LVEF of 30%. He was discharged 3 weeks later fully recovered. MIS-A should be considered if a compatible syndrome is observed in patients with evidence of SARS-CoV-2 infection by PCR test or serology.
Learning points: Multisystem inflammatory syndrome should be considered in young adults presenting with shock and elevated inflammatory markers.Multisystem inflammatory syndrome may be highly responsive to parenteral steroids.
Keywords: SARS-CoV-2; adult patients; multisystem inflammatory syndrome.
© EFIM 2021.
Conflict of interest statement
Conflicts of Interests: The authors declare there are no competing interests.
Figures
Similar articles
-
Four Distinct Cases of Multisystem Inflammatory Syndrome in Adults Associated With SARS-CoV-2 Infection at a Community Hospital in New Jersey.Cureus. 2021 Dec 23;13(12):e20651. doi: 10.7759/cureus.20651. eCollection 2021 Dec. Cureus. 2021. PMID: 35103207 Free PMC article.
-
Multisystem inflammatory syndrome in an adult (MIS-A) due to SARS-CoV-2 infection presenting to a South African hospital.BMJ Case Rep. 2022 Feb 8;15(2):e246587. doi: 10.1136/bcr-2021-246587. BMJ Case Rep. 2022. PMID: 35135793 Free PMC article.
-
Autoantibody Release in Children after Corona Virus mRNA Vaccination: A Risk Factor of Multisystem Inflammatory Syndrome?Vaccines (Basel). 2021 Nov 18;9(11):1353. doi: 10.3390/vaccines9111353. Vaccines (Basel). 2021. PMID: 34835284 Free PMC article.
-
Multisystem inflammatory syndrome with persistent neutropenia in neonate exposed to SARS-CoV-2 virus: A case report and review of literature.J Neonatal Perinatal Med. 2022;15(2):373-377. doi: 10.3233/NPM-210839. J Neonatal Perinatal Med. 2022. PMID: 34459420 Review.
-
Shock and Myocardial Injury in Children With Multisystem Inflammatory Syndrome Associated With SARS-CoV-2 Infection: What We Know. Case Series and Review of the Literature.J Intensive Care Med. 2021 Apr;36(4):392-403. doi: 10.1177/0885066620969350. Epub 2020 Nov 5. J Intensive Care Med. 2021. PMID: 33148089 Review.
Cited by
-
The Management of COVID-19-Related Coagulopathy: A Focus on the Challenges of Metabolic and Vascular Diseases.Int J Mol Sci. 2023 Aug 14;24(16):12782. doi: 10.3390/ijms241612782. Int J Mol Sci. 2023. PMID: 37628963 Free PMC article. Review.
References
-
- Centers for Disease Control and Prevention. Information for healthcare providers about multisystem inflammatory syndrome in children (MIS-C) [accessed 10 Oct 2021]. Available from: https://www.cdc.gov/mis-c/hcp/
-
- Centers for Disease Control and Prevention. Multisystem inflammatory syndrome in adults (MIS-A) [accessed 10 Oct 2021]. Available from: https://www.cdc.gov/mis-c/mis-a.html.
-
- Morris SB, Schwartz NG, Patel P, Abbo L, Beauchamps L, Balan S, et al. Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection - United Kingdom and United States, March–August 2020. MMWR Morb Mortal Wkly Rep. 2020;69(40):1450–1456. doi: 10.15585/mmwr.mm6940e1. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous